Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to all patients.
The Company's multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products. Evotec leverages this "Data-driven R&D Autobahn to Cures" for proprietary projects and within a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders.
Evotec has strategic activities in a broad range of currently under served therapeutic areas, including neurology and oncology, as well as metabolic and infectious diseases. Within these areas of expertise, Evotec aims to create the world's leading co-owned pipeline for innovative therapeutics and has to-date established a portfolio of more than 200 proprietary and co-owned R&D projects from early discovery to clinical development.
Evotec operates globally with more than 4,000 highly qualified employees. The Company's 14 sites offer highly synergistic technologies and services and operate as complementary clusters of excellence.
- Focus : Manufacturer
- Employees: 501-1,000
- Industry : Pharma
News about Evotec
11-Jul-2013 | research and development
Evotec and Dow AgroSciences announce collaboration on Cellular Target Profiling
Evotec AG announced that Evotec and Dow AgroSciences (DOW) have entered into a research collaboration with the objective of leveraging Evotec's chemical ...
10-Jul-2013 | business & finance
Evotec to realign Discovery Chemistry Operations
Evotec AG announced that it will close its Chemistry Operations in Thane, India. All chemistry efforts will now be performed at its Abingdon (UK) facility ...
07-May-2012 | business & finance
Evotec AG announces multi-year agreement with The United States Environmental Protection Agency (EPA)
Evotec AG announced that Evotec has entered into a multi-year compound management agreement with the United States EPA. The contract covers a period of ...
15-Jan-2007 | business & finance
PerkinElmer Completes Acquisition of Euroscreen Products SA And Evotec Technologies
PerkinElmer, Inc. reported that it has successfully completed two previously announced acquisitions that will extend its portfolio of advanced tools for ...
04-Dec-2006 | business & finance
PerkinElmer to Acquire Evotec Technologies
PerkinElmer, Inc. announced that it has signed a definitive agreement with Evotec AG to acquire its majority owned subsidiary, Evotec Technologies GmbH, in ...
25-Jul-2005 | business & finance
Procter & Gamble Selects Evotec as Provider of Pharmaceutical Discovery and Chemical Development Services
Evotec AG and Procter & Gamble Pharmaceuticals, Inc. (P&GP), a subsidiary of The Procter & Gamble Company announced that they have entered into agreements ...
19-Jul-2004 | business & finance
Biogen Idec Selects Evotec OAI as a Service Provider for Process Research & Development
Evotec OAI AG a leading partner for integrated, high-value-added drug discovery and development solutions, today announced that Biogen Idec has selected ...